114 results
8-K
EX-99.1
ABBV
Abbvie Inc
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
financial performance and made a remarkable impact on patients and the communities we serve."
"I want to thank Rick for his exceptional leadership since
424B5
ABBV
Abbvie Inc
26 Feb 24
Prospectus supplement for primary offering
6:12am
leadership positions across immunology, oncology, aesthetics, neuroscience and eye care. AbbVie uses its expertise, dedicated people and unique approach … positioned for success with a comprehensive product portfolio that has leadership positions across immunology, hematologic oncology, neuroscience
424B5
4ckc5xf9
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
g774xww 0ckvl
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
PX14A6G
gf3zkl8 oiddlv
4 May 23
Letter to shareholders
8:08am
8-K
EX-99.1
bqokfq6 0jb431s
28 Oct 22
AbbVie Reports Third-Quarter 2022 Financial Results
7:48am
8-K
EX-99.1
8cs9fdoiwzk7jj7es6op
17 Oct 22
Departure of Directors or Certain Officers
9:05am
CORRESP
8vjpxmo6grj7xhbpg
4 Oct 22
Correspondence with SEC
12:00am
UPLOAD
cb3dyf30fwtklc bdhw
20 Sep 22
Letter from SEC
12:00am
8-K
EX-99.1
mpkfoso2
29 Jul 22
AbbVie Reports Second-Quarter 2022 Financial Results
7:49am